Subcutaneous mepolizumab in children aged 6 to 11 years with severe eosinophilic asthma

Gupta, A; Pouliquen, I; Austin, D; Price, RG; Kempsford, R; Steinfeld, J; Bradford, ES; Yancey, SW

Steinfeld, J (reprint author), GSK, Resp TAU & Flexible Discovery Unit, Upper Providence UP1210, Collegeville, PA 19426 USA.

PEDIATRIC PULMONOLOGY, 2019; 54 (12): 1957

Abstract

ObjectivesThere are no published reports for anti-interleukin-5 therapy in children <12 years with asthma. The primary objective of this study was ......

Full Text Link